SCHEMBL1375577

SCHEMBL1375577

c1ccc2cc(-c3c4ccccc4c(-c4cc5ccc6ccccc6c5c5ccccc45)c4ccccc34)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.42
GPR84 Q9NQS5 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NQO2 P16083 2/20 0.40
HDAC4 P56524 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
ALOX5 P09917 2/20 0.38
CYP1B1 Q16678 2/20 0.37
CYP1A1 P04798 1/20 0.37
ALDH1A1 P00352 4/20 0.37
HSD17B10 Q99714 4/20 0.37
TSHR P16473 2/20 0.37
CYP1A2 P05177 2/20 0.37
HPGD P15428 2/20 0.37
HIF1A Q16665 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1375575 0.86 KDM4E (0.48) GPR84KDM4EMEN1KMT2ANQO2
SCHEMBL13010579 0.85 GPR84 (0.36) GSTP1GPR84KDM4EMEN1KMT2A
SCHEMBL20127333 0.84 ABCG2 (0.41) GSTP1GPR84MEN1KMT2ACYP1B1
SCHEMBL13010585 0.84 PIM1 (0.41) GSTP1GPR84KDM4EMEN1KMT2A
SCHEMBL25784829 0.83 GPR84 (0.37) GSTP1GPR84KDM4EMEN1KMT2A
SCHEMBL20127738 0.83 ABCG2 (0.40) GSTP1GPR84MEN1KMT2AESR1
SCHEMBL16067878 0.83 CDK4 (0.39) KDM4EMEN1KMT2ANQO2CYP1B1
SCHEMBL16067579 0.83 CDK4 (0.38) KDM4EMEN1KMT2ANQO2CYP1B1
SCHEMBL27961488 0.83 GPR84 (0.47) GSTP1GPR84MEN1KMT2AHDAC4
SCHEMBL20127295 0.82 ABCG2 (0.40) KDM4EMEN1KMT2ACYP1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006503-B2 Organic electroluminescence devices containing substituted benzo[C]phenanthrenes MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
CN-102282234-B Material for organic electroluminescent device MERCK PATENT GMBH 2014-07-30 CN disclosed
US-8710284-B2 Materials for organic electroluminescent devices containing substituted 10-benzo[c]phenanthrenes MERCK PATENT GMBH (DE) 2014-04-29 US disclosed
US-20140114076-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-04-24 US disclosed
CN-102282234-A Material for organic electroluminescent device 2011-12-14 CN disclosed
US-20110288292-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2011-11-24 US disclosed
WO-2010083869-A2 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2010-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288292-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES DDT, DDC, BMI1 GSTP1 530/4885GPR84 3695/4885KDM4E 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.